- Take the Leukemia Quiz!
- 15 Cancer Symptoms Women Ignore Slideshow
- Cancer Symptoms Men Ignore Slideshow
- What is dasatinib, and how does it work (mechanism of action)?
- What brand names are available for dasatinib?
- Is dasatinib available as a generic drug?
- Do I need a prescription for dasatinib?
- What are the side effects of dasatinib?
- What is the dosage for dasatinib?
- Which drugs or supplements interact with dasatinib?
- Is dasatinib safe to take if I'm pregnant or breastfeeding?
- What else should I know about dasatinib?
What is dasatinib, and how does it work (mechanism of action)?
: Dasatinib is an oral medication used for treating chronic myeloid leukemia and acute lymphoblastic leukemia. It is classified as a kinase inhibitor. Kinase inhibitors include Erlotinib (Tarceva), gefitinib (Iressa), imatinib (Gleevec), nilotinib (Tasigna), pazopanib (Votrient), sunitinib (Sutent), and vandetanib (Caprelsa). Kinase inhibitors prevent the growth of tumors by reducing the action of proteins that control cell division, growth, and survival. These proteins are usually present in larger quantities or are more active in cancer cells. By reducing the activity of these proteins, growth and survival of cancer cells are reduced. The FDA approved dasatinib in June 2006.
What are the side effects of dasatinib?
Common side effects are:
- fluid retention,
- nausea and vomiting,
- abdominal distention,
- weight loss or gain,
- dizziness, and
- muscle pain.
Other important and serious side effects of dasatinib include:
What is the dosage for dasatinib?
The recommended dose range of dasatinib is 100-180 mg orally once daily. For newly diagnosed Ph+ CML treatment starts at 100 mg and is increased to 140 mg daily as needed. For advanced Ph+ CML or Ph+ ALL treatment is started at 140 mg and increased to 180 mg daily as needed.
Which drugs or supplements interact with dasatinib?
The blood concentration of dasatinib may be increased by several drugs that reduce its break down by liver enzymes. Increased blood concentrations of dasatinib may increase the occurrence of adverse effects. Examples include ketoconazole, itraconazole (Sporanox), clarithromycin (Biaxin), atazanavir (Reyataz), indinavir (Crixivan), nelfinavir (Viracept), ritonavir (Norvir), saquinavir (Invirase), telithromycin (Ketek), voriconazole (Vfend), and grapefruit juice. A dose reduction should be considered if there are no alternative medications that will not interact with dasatinib, for example a reduction in dose from 100 mg to 20 mg or 140 mg to 40 mg daily.
Certain drugs decrease the concentration of dasatinib resulting in decreased blood levels and possibly reduced effect. Examples include dexamethasone, carbamazepine, phenobarbital, rifampin, phenobarbital, and St John's Wort. A dose increase should be considered if dasatinib is combined with such drugs.
Drugs that reduce production of acid in the stomach reduce the absorption of dasatinib. Examples include proton pump inhibitors (PPIs) such as omeprazole (Prilosec) and H2 blocking drugs such as famotidine (Pepcid). Antacids used 2 hours before or after administration of dasatinib are reasonable alternatives to drugs that reduce the production of acid in the stomach.
Dasatinib increases the blood concentration of simvastatin (Zocor) by reducing the activity of enzymes that break down simvastatin in the liver. This may increase the side effects of simvastatin. Dasatinib may interact with other drugs that are broken down in a similar way as simvastatin.
Is dasatinib safe to take if I'm pregnant or breastfeeding?
Dasatinib is harmful to the fetus and should not be used during pregnancy.
It is unknown whether dasatinib is excreted in human milk.
What else should I know about dasatinib?
What preparations of dasatinib are available?
Tablets: 20, 50, 70, 80, 100, and 140 mg
How should I keep dasatinib stored?
Dasatinib should be stored at room temperature between 15 C - 30 C (59 F -86 F).
Latest Cancer News
Dasatinib (Sprycel) is a kinase inhibitor drug prescribed for the treatment of newly diagnosed Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML); treatment of chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib; and treatment of Ph+ acute lymphoblastic leukemia (ALL) with resistance or intolerance to prior therapy. Drug interactions, dosing, side effects, and warnings and precautions should be reviewed prior to taking any medication.
Multimedia: Slideshows, Images & Quizzes
Related Disease Conditions
Leukemia is a type of cancer of the blood cells in which the growth and development of the blood cells are abnormal. Strictly speaking, leukemia should refer only to cancer of the white blood cells (the leukocytes) but in practice it can apply to malignancy of any cellular element in the blood or bone marrow, as in red cell leukemia (erythroleukemia).
Cancer is a disease caused by an abnormal growth of cells, also called malignancy. It is a group of 100 different diseases, and is not contagious. Cancer can be treated through chemotherapy, a treatment of drugs that destroy cancer cells.
Treatment & Diagnosis
Medications & Supplements
Prevention & Wellness
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.